Search 33,000+ CME courses
Back

StatPearls, LLC

  • Allopurinol
  • Febuxostat
  • Gout
  • Hyperuricemia

Febuxostat

An educational discussion of managing hyperuricemia conditions, including gout, is essential for healthcare providers. This session addresses the indications, mechanism of action, administration guidelines, adverse event profile, contraindications, and monitoring strategies for febuxostat, a xanthine oxidase inhibitor. Given recent FDA recommendations regarding cardiovascular risks associated with febuxostat compared to allopurinol, understanding when to opt for febuxostat over allopurinol is crucial. Furthermore, understanding febuxostat’s pharmacology empowers healthcare professionals to tailor treatment plans to individual patient needs, optimizing therapeutic efficacy while minimizing potential adverse effects. By integrating dosing considerations, pharmacokinetic insights, toxicity profiles, and pertinent drug interactions, healthcare providers can make informed decisions to enhance patient care outcomes in managing gout and related conditions. This activity facilitates an in-depth exploration of febuxostat’s role within the therapeutic landscape, fostering a holistic understanding of its clinical utility and challenges. This session enhances a clinician’s ability to navigate febuxostat therapy effectively by equipping healthcare professionals with the requisite knowledge and skills. Through proactive monitoring and thoughtful consideration of patient-specific factors, healthcare providers can mitigate risks and maximize benefits associated with febuxostat treatment, ultimately improving outcomes for individuals with gout or hyperuricemia.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABOS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

More from StatPearls, LLC

See all

This provider’s courses closest to this one